| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $7.5B | $6.1B | $6.0B | $7.6B | $9.2B | $2.2B | $1.7B | $1.4B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.6B | $0.1B | $0.2B | $0.3B | $1.2B | $0.3B | $0.2B | $0.1B |
| EPS (Basic) | $6.02 | $1.26 | $2.08 | $2.46 | $11.18 | $2.50 | $1.98 | $0.81 |
| EPS (Diluted) | $6.00 | $1.26 | $2.07 | $2.45 | $11.14 | $2.49 | $1.97 | $0.81 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $16.2B | $14.9B | $16.8B | $15.0B | $16.5B | $12.8B | $11.5B | $10.6B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $1.4B | $1.7B | $3.6B | $1.2B | $1.2B | $1.3B | $1.5B | $1.5B |
| Total Liabilities | $10.7B | $10.0B | $11.9B | $10.3B | $10.7B | $7.9B | $7.1B | $6.9B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $5.5B | $4.9B | $4.8B | $4.7B | $5.8B | $4.9B | $4.4B | $3.7B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.0B | $0.9B | $0.4B | $0.8B | $1.2B | $1.1B | $0.9B | $0.8B |
| Investing Cash Flow | $-1.5B | $-0.5B | $0.6B | $-0.4B | $-3.4B | $-1.4B | $-0.5B | $-1.2B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $0.2B | $-2.3B | $1.4B | $-0.4B | $2.1B | $0.1B | $-0.4B | $0.5B |